A new immunosuppressant, FTY720, in canine kidney transplantation: Effect of single-drug, induction and combination treatments

Transplant International

Volumn 17, Issue 10, 2004, Pages 574-584

  Suzuki, Tomomi ^a   Jin, Maeng Bong ^a   Shimamura, Tsuyoshi ^a   Yamashita, Kenichiro ^a   Taniguchi, Masahiko ^a   Nomura, Masaru ^a   Yokota, Ryouichi ^a   Fukai, Moto ^a   Magata, Shinichiro ^a   Horiuchi, Hiroyuki ^a   Fujita, Miri ^a   Nagashima, Kazuro ^a   Furukawa, Hiroyuki ^a   Todo, Satoru ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Canine kidney transplantation; Combination treatment; Cyclosporine; FTY720; Induction treatment; Single drug treatment; Tacrolimus

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A; FINGOLIMOD; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD EXAMINATION; CHEMICAL ANALYSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOG; DOSE RESPONSE; FEMALE; GRAFT SURVIVAL; HISTOPATHOLOGY; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ANIMALS; BLOOD CELL COUNT; CORONARY VESSELS; CYCLOSPORINE; DOGS; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; INTESTINES; KIDNEY; LIVER TRANSPLANTATION; LUNG; PROPYLENE GLYCOLS; SPHINGOSINE; SURVIVAL ANALYSIS; TACROLIMUS;

EID: 19944429661     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2004.tb00389.x     Document Type: Article

References (32)

1. Quesniaux V, Fullard L, Arendse H, et al. A novel immunosuppressant, FTY720, induces peripheral lymphodepletion of both T- and B cells and immunosuppression in baboons. Transpl Immunol 1999; 7:149.
2. Budde K, L Schmouder R, Nashan B, et al. Pharmacodynamics of single doses of the novel immunosuppressant FTY720 in stable renal transplant patients. Am J Transplant 2003; 3:846.
3. Bohler T, Waiser J, Schutz M, et al. FTY 720A mediates reduction of lymphocyte counts in human renal allograft recipients by an apoptosis- independent mechanism. Transpl Int 2000; 13:S311.
4. Budde K, Schmouder RL, Brunkhorst R, et al. First human trial of FTY720, a novel immunomodulator, in stable renal transplant patients. J Am Soc Nephrol 2002; 13:1073.
5. Brinkmann V, Davis MD, Heise CE, et al. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem 2002; 277:21453.
6. Henning G, Ohl L, Junt T, et al. CC chemokine receptor 7-dependent and - independent pathways for lymphocyte homing: modulation by FTY720. J Exp Med 2001; 194:1875.
7. Chiba K, Yanagawa Y, Masubuchi Y, et al. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. J Immunol 1998; 160:5037.
8. Yanagawa Y, Masubuchi Y, Chiba K. FTY 720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats, III. Increase in frequency of CD62L-positive T cells in Peyer's patches by FTY720-induced lymphocyte homing. Immunology 1998; 95:591.
9. Suzuki S, Enosawa S, Kakefuda T, et al. A novel immunosuppressant, FTY720, with a unique mechanism of action, induces long-term graft acceptance in rat and dog allotransplantation. Transplantation 1996; 61:200.
10. Enosawa S, Suzuki S, Kakefuda T, Li XK, Amemiya H. Induction of selective cell death targeting on mature T-lymphocytes in rats by a novel immunosuppressant, FTY720. Immunopharmacology 1996; 34:171.
11. Matsuda S, Minowa A, Suzuki S, Koyasu S. Differential activation of c-Jun NH2-terminal kinase and p38 pathways during FTY720-induced apoptosis of T lymphocytes that is suppressed by the extracellular signal-regulated kinase pathway. J Immunol 1999; 162:3321.
12. Okazaki H, Hirata D, Kamimura T, et al. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus. J Rheumatol 2002; 29:707.
13. Azuma H, Takahara S, Ichimaru N, et al. Marked prevention of tumor growth and metastasis by a novel immunosuppressive agent, FTY720, in mouse breast cancer models. Cancer Res 2002; 62:1410.
14. Azuma H, Takahara S, Horie S, Muto S, Otsuki Y, Katsuoka Y. Induction of apoptosis in human bladder cancer cells in vitro and in vivo caused by FTY720 treatment. J Urol 2003; 169:2372.
15. Chiba K, Hoshino Y, Suzuki C, et al. FTY720, a novel immunosuppressant possessing unique mechanisms. I. Prolongation of skin allograft survival and synergistic effect in combination with cyclosporine in rats. Transplant Proc 1996; 28:1056.
16. Wang ME, Tejpal N, Qu X, et al. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus. Transplantation 1998; 65:899.
17. Xu M, Pirenne J, Antoniou EA, Afford SC, D'Silva M, McMaster P. Effect of peritransplant FTY720 alone or in combination with post-transplant tacrolimus in a rat model of cardiac allotransplantation. Transpl Int 1998; 11:288.
18. Yamasaki T, Inoue K, Hayashi H, et al. Effect of a new immunosuppressive agent, FTY720, on survival of islet allografts. Cell Transplant 1998; 7:403.
19. Zhang L, Zhu T, Sun EW, Shen SQ, Min ZL, Chen ZK. Pretreatment with FTY720 alone induced long-term survival of mouse heart allograft. Transplant Proc 2003;35:567.
20. Troncoso P, Stepkowski SM, Wang ME, et al. Prophylaxis of acute renal allograft rejection using FTY720 in combination with subtherapeutic doses of cyclosporine. Transplantation 1999; 67:145.
21. Tamura A, Li XK, Funeshima N, et al. Immunosuppressive therapy using FTY720 combined with tacrolimus in rat liver transplantation. Surgery 2000; 127:47.
22. Furukawa H, Suzuki T, Jin MB, et al. Prolongation of canine liver allograft survival by a novel immunosuppressant, FTY720: effect of monotherapy and combined treatment with conventional drugs. Transplantation 2000; 69:235.
23. Nikolova Z, Hof A, Baumlin Y, Hof RP. The peripheral lymphocyte count predicts graft survivals in DA to Lewis heterotopic heart transplantation treated with FTY720 and SDZ RAD. Transpl Immunol 2000; 8:115.
24. Quesniaux V, Menninger K, Audet M, Gaschen L, Schuurman HJ. FTY-720 is efficacious in monkey kidney transplantation. Transplant Proc 2001; 33:2374.
25. Nikolova Z, Hof A, Baumlin Y, Hof RP. Efficacy of SDZ RAD compared with CsAmonotherapy and combined Rad/FTY720 treatment in a murine cardiac allotransplantation model. Transpl Immunol 2001; 9:43.
26. Tedesco H, Kahan B, Mourad G, et al. FTY720 combined with Neoral and corticosteroids is effective and safe in prevention of acute rejection in renal allograft recipients (interim data). Am J Transplant 2001; 1:A429.
27. Skerjanec A, Hsu CH, Pellet P, Chodoff L, Schmouder R, Sablinski T. Systemic exposure and preliminary efficacy of FTY720 in denovo renal transplant recipients. Am J Transplant 2002; 2:A964.
28. Omura T, Suzuki T, Shimamura T, et al. A short-course therapy with FTY720 prolongs allograft survival after canine kidney transplantation. Transplant Proc 1999; 31:2783.
29. Yanagawa Y, Hoshino Y, Chiba K. The significance of timing of FTY720 administration on the immunosuppressive effect to prolong rat skin allograft survival. Int J Immunopharmacol 2000; 22:597.
30. Chueh SC, Tsai CC, Chiu B, Li YC, Lai MK. Rescuing acute rejection of rat cardiac allografts with FTY720. Transplant Proc 2000; 32:1629.
31. Li XK, Tamura A, Fujino M, et al. Induction of lymphocyte apoptosis in rat liver allograft with ongoing rejection by FTY720. Clin Exp Immunol 2001; 123:331.
32. Kahan BD. FTY720: a new immunosuppressive agent with novel mechanism(s) of action. Transplant Proc 1998; 30:2210.